Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
- PMID: 38504384
- PMCID: PMC10949674
- DOI: 10.1186/s13722-024-00448-8
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
Abstract
Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).
Keywords: Addiction medicine; Alcohol use disorder; Alcohol-associated liver disease; Hepatology; Treatment.
© 2024. The Author(s).
Conflict of interest statement
None to disclose.
Figures
References
-
- Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the national epidemiologic survey on alcohol and related conditions. JAMA Psychiat. 2017;74(9):911–923. doi: 10.1001/JAMAPSYCHIATRY.2017.2161. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
